Background: Hexokinase I sets the pace of glycolysis in the brain, catalyzing the ATP-dependent phosphorylation of glucose. The catalytic properties of hexokinase I are dependent on product inhibition as well as on the action of phosphate. In vivo, a large fraction of hexokinase I is bound to the mitochondrial outer membrane, where the enzyme adopts a tetrameric assembly. The mitochondrion-bound hexokinase I is believed to optimize the ATP/ADP exchange between glucose phosphorylation and the mitochondrial oxidative phosphorylation reactions.
Introduction
Hexokinase (ATP: D-hexose 6-phosphate transferase, EC 2.7.1.1) is the first enzyme in the glycolytic pathway and catalyzes the ATP-based phosphorylation of glucose to glucose-6-phosphate (G6P). In mammals four hexokinase isozymes have been identified (named I-IV), which differ in their catalytic and regulatory properties as well as in their tissue localization. Hexokinases I, II and III (HK-I, HK-II and HK-III, respectively) each have a similar molecular mass (approximately 100 kDa), whereas glucokinase (hexokinase IV, HK-IV) is a single chain, 50 kDa enzyme [1] . G6P, the reaction product, is a potent inhibitor of HK-I and inorganic phosphate (P i ), at physiological concentrations, can relieve this inhibition [1, 2] .
The crystal structures of the human and rat HK-I isozymes (both approximately 100 kDa) and of Schistosoma mansoni hexokinase (approximately 50 kDa) have been reported recently [2] [3] [4] [5] , following the pioneering crystallographic analysis of yeast hexokinase (approximately 50 kDa) [6, 7] . Human brain HK-I polypeptide chain is composed of 917 amino acids [8] , organized in two domains that roughly encompass the N-terminal (residues 1-474) and the C-terminal halves (475-917) [2] [3] [4] . The two domains display extensive sequence similarities (approximately 70% amino acid identities; [9] ). Moreover, each domain is structurally related to yeast hexokinase, supporting the view that mammalian hexokinases evolved from a common ancestral enzyme, of approximately 50 kDa, by gene duplication and fusion [1, 2, 9, 10] .
Both human and rat HK-I are found to adopt a dimeric structure in the crystalline state. Within the dimer, the N-terminal domain from one subunit is juxtaposed to the C-terminal domain of the second subunit, the molecular symmetry of the dimer being close to, or exactly, a twofold axis [2] [3] [4] . The connection between the N-and C-terminal domains of each subunit is provided by an extended α helix, and their mutual interaction is mediated by a limited number of intramolecular contacts (at Arg69, Glu249, Asp251, Glu252, Leu797, Arg801, Cys813 and Asp814). As shown for the single-domain yeast hexokinase structure, one small and one large subdomain can be distinguished in the N-and C-terminal domains of HK-I. Upon glucose binding, relative movements of the small and large subdomains allow the enzyme to adopt the so-called 'closed' conformation [7, 11] .
Solution studies, controlled proteolysis and site-directed mutagenesis, as well as recent crystallographic investigations, have shown that the catalytic action of HK-I is associated with the C-terminal domain, which binds glucose and the product G6P at distinct, neighboring, sites. Product inhibition of the enzyme has been related to the competition between ATP and G6P for a specific binding site within the catalytic centre preventing glucose phosphorylation [12] . Alternatively, G6P could bind to the N-terminal domain as an allosteric inhibitor, modulating the catalytic activity through interdomain contacts [5, 12, 13] . In both models, G6P inhibition is relieved by binding of P i at the N-terminal regulatory domain, resulting in either competition with G6P or allosteric modulation of G6P binding to the C-terminal domain [4, 12] .
Mammalian HK-I is known to bind specifically and cooperatively, under physiological conditions, at pores of the outer mitochondrial membrane, through an N-terminal hydrophobic sequence (residues 1-11), which is inserted into the lipid membrane space [14, 15] . Association of the enzyme with the contact sites between the outer and the inner mitochondrial membranes promotes the formation of hexokinase tetramers, which may assemble into a multiprotein complex with porin, facilitating the ATP/ADP traffic from/to the mitochondrial matrix, and eventually from/to the oxidative phosphorylation cascade [16, 17] . Moreover, mitochondrial outer membrane binding studies on different molecular constructs of the mammalian enzymes have shown that the isolated, catalytically active, C-terminal domain is not capable of binding, as opposed to the observed binding of the isolated N-terminal domain [18] . Proteolytic cleavage of the N-terminal hydrophobic segment 1-11, from the intact HK-I molecule or from the isolated N-terminal domain, removes the enzyme-membrane binding properties. On the other hand, it has been shown that millimolar concentrations of nucleotidetriphosphates, such as ATP, CTP, GTP and UTP, as well as of pyrophosphate, favour hexokinase dissociation from the outer mitochondrial membrane, an effect that can be partially counterbalanced by Mg 2+ [2] [3] [4] 19] . Moreover, G6P (at 0.2 mM levels) is able to affect the intracellular distribution of the enzyme, promoting the release of the mitochondria-bound forms [1, 19, 20] . The central role of the enzyme N-terminal domain in mitochondrial membrane association has been supported further by mapping of the HK-I epitopes with monoclonal antibodies [21] .
Such a structural and functional organization is believed to be of physiological significance in regulation of the enzyme activity and of the glycolytic flux in vivo. Similar mitochondria association properties have been shown to be present in the N-terminal domain of mammalian HK-II, but are lacking for HK-III, which has been shown to be localized at the nuclear periphery [1, 18] . In this context, despite the multiple functions displayed by ATP in hexokinase activity, it is remarkable that no crystal structures of hexokinase-ATP complexes are yet available.
We have investigated the issue of HK-I membrane association control through X-ray crystallography, analyzing crystals of the human recombinant enzyme (in a truncated form missing the N-terminal residues 1-11, tHK-I), grown in the presence of the non-hydrolyzable ATP analogue 5′-adenylylimido-diphosphate (AMP-PNP), at 2.25 Å resolution. The results presented here show that AMP-PNP binds at a previously unidentified surface cleft in each N-terminal domain of the dimeric tHK-I. This region of positive electrostatic potential is proposed to be a key component of the hexokinase molecular interface to the mitochondrial outer membrane.
Results and discussion

Structure determination and model quality
Solution of the crystal structure of tHK-I in a monoclinic crystal form (space group P2 1 ), obtained in the presence of the nucleotide analogue, glucose, G6P, and displaying one tHK-I dimer per asymmetric unit, was achieved through molecular replacement methods, using the AMoRe program package from the CCP4 suite [22] . The atomic coordinates of recombinant human hexokinase I, crystallized in a different monoclinic crystal form in the presence of glucose and G6P [2] , were used as model for the molecular replacement analysis, providing unequivocal solutions for both the rotational and the translational searches. The resulting model was refined to 2.25 Å resolution, against an X-ray diffraction data set collected at 100K at the European Synchrotron Radiation Facility (Grenoble, France), with final crystallographic R factor of 20.8%, and R free of 27.9% (see the Materials and methods section). During the crystallographic refinement, the bound glucose, G6P and AMP-PNP molecules were promptly identified as strong difference electron density features in both tHK-I chains, but introduced only in the later stages (R factor <25%), when they could be accurately modelled. The refined tHK-1 dimer model consists of 1802 amino acid residues, 4 glucose, 4 G6P, 6 Mg 2+ ions, 459 water molecules, and 2 bound AMP-PNP moieties ( Figure 1 ; Table 1 ). Interpretable electron density is available for chain A, starting from residue Thr12, whereas the first residue in density, for chain B, is Asp16. No electron density is observed for residues Glu100-Gln103 (both chains) and for residues Thr913-Glu914 (A chain). The structure quality assessment together with relevant crystallographic statistics is reported in Table 1 ; no residues are observed out of the allowed Ramachandran regions [23] .
The molecular assembly and fold
As previously described for recombinant human HK-I [2] [3] [4] [5] and for rat HK-I, each tHK-I chain is composed of an N-terminal and a C-terminal domain, which reflect the gene-duplication evolutionary origin of this hexokinase isoform [1, 10] . Accordingly, the two domains, which are separated by a connection helix, have approximately the same size (approximately 450 residues) and show comparable folds (Figure 1 ), structurally related to the polypeptide fold observed in the approximately 50 kDa yeast and Schistosoma mansoni hexokinases [5] [6] [7] . Moreover, because of the presence of glucose in the crystallization buffer and in the crystallized enzyme, both the N-and C-terminal domains adopt a closed conformation, which is held to shape the active site properly, favouring ATP→glucose phosphoryl transfer, during the catalytic cycle [24, 25] . A structural overlay of the Cα backbones of the core residues in the N-and C-terminal domains of tHK-I yields a root mean square deviation (rmsd) of 1.14 Å (calculated using 232 Cα atom pairs).
Each tHK-I subunit is related to its asymmetric unit mate by an almost exact twofold axis, which is oriented parallel to the unit-cell face defined by the b and c axes, forming an angle of about 35° with respect to the c direction. The location of the molecular twofold axis juxtaposes the N-terminal domain of the A subunit next to the C-terminal domain of the B subunit ( Figure 1 ). In accordance with such highly symmetric assembly of the tHK-I dimer, in a trigonal crystal form of human HK-I (space group P3 2 21), crystallized in the presence of glucose and P i only, the molecular twofold axis of the dimeric enzyme is coincident with a crystallographic dyad [3] . The total subunit interface area that is shielded from solvent (1.4 Å radius probe), upon formation of the tHK-I dimer, is 2014 Å 2 . The packing of tHK-I dimers in the crystal lattice does not shed light, however, on models for additional quaternary structure aggregation in a tetrameric form of the enzyme. In this respect it has been noticed previously that tetramer formation is correlated with binding of HK-I to mitochondria [4, 16] .
The optimal overlay of the full Cα backbones of tHK-I subunits A against B yields an rmsd of 0.51 Å (calculated using 892 Cα atom pairs). This value is comparable with the rmsd calculated for each individual subunit, and for the full tHK-I dimer, with respect to the molecular replacement search model that was refined at 2.8 Å resolution (rmsd 0.85 Å, 0.75 Å, and 0.96 Å, respectively). All the preceding figures indicate the absence of significant quaternary and tertiary structure rearrangements between crystal forms of human (t)HK-I, obtained in the presence of saturating glucose and G6P concentrations, although influence of crystal contacts on the dynamics of the enzyme molecule (as displayed by the atomic thermal parameters) has been reported [4] . In view of such a structural conservation, no further discussion is devoted here to a description of tHK-I general structure assembly [2] [3] [4] [5] . In this context it should nevertheless be mentioned that a total of four (structural) cation binding sites have been recognized at structurally equivalent loops located at the N-and C-terminal domain interface of each chain (loops 241-253 and 691-703), as previously reported for human HK-I [3] . Because of electrostatic compensation of neighbouring residues, and the presence of 200 mM MgSO 4 in the crystallization buffer, the bound cations have been modelled as full occupancy Mg 2+ ions (displaying refined B factors of 41.7 Å 2 , 56.0 Å 2 , 28.8 Å 2 , 35.7 Å 2 , in the N-and in the C-terminal domains of chains A and B, respectively).
Glucose-and G6P-binding sites
In relation to the relatively high crystallographic resolution achieved, the tHK-I model presented here allows a clear characterization of the glucose-and G6P-binding sites, observed in the N-and C-terminal domains ( Figure 2 ; Table 2 ). In particular, as indicated by unequivocal difference electron-density peaks in the final stages of the refinement, the glucose molecule, which had been initially modelled in the β-anomer configuration, is indeed present as the α-anomer in all four domains of the tHK-I dimer. Such an observation is supported further by inspection of atomic B factors, which refine to values 50% higher than those of the neighbouring atoms, when the glucose O1 atom is refined in the β position. Moreover, all the four glucose molecules (which have been refined with a constant occupancy of 1.0) show similar average B factors (33.6 Å 2 , 34.9 Å 2 , 31.7 Å 2 and 28.9 Å 2 , in the N-and C-terminal domains of chains A and B, respectively), indicating that the glucose binding processes occur with comparable efficiency at the different domains, under the tHK-I crystal growth conditions. The presence of the glucose α-anomer is unexpected because previous crystallographic reports suggested either the presence of the β-anomer (for human HK-I) or of both the αand β-anomers (for rat HK-I) [1, 26, 27] .
The glucose molecule is fully solvent inaccessible, within the protein core, in both tHK-I domains. Despite the presence of the α-anomer, the glucopyranose ring provides substrate-protein interactions which are, in general, in line with the hydrogen bonding and van der Waals contacts scheme proposed for human [2] , for rat HK-I [5] and for yeast HK [1, 7] , with additional interactions occurring at the O5 glucose atom. On the other hand, comparison of the hydrogen-bonding assignments for tHK-I ( Table 2) with those reported for human and for rat HK-I [2, 5] shows that partial modification of the ligand-binding interactions can be recognized at the G6P-binding sites of tHK-I. In this respect, inspection of the atomic B factors and of residual electron density shows that G6P is present as the β-anomer and does not suggest different product occupancies in the four binding sites present in the asymmetric unit, nor alternative binding modes, as previously proposed [2] . The observation of partly modified protein-ligand interactions at both N-and C-terminal domains for both glucose and G6P, as compared with the other mammalian hexokinase structures previously reported, might be related, in general, to a slight contraction of the protein molecule at 100K, might result from the selection of the α-D-glucose anomer, but might also reflect a more accurate electrondensity fitting, related to improvements in the crystallographic resolution achieved for tHK-I. 
Figure 2
Glucose-binding site. A view of the electron density observed for the glucose and G6P molecules in the tHK-I C-terminal domain binding site (chain A). The electron density is contoured at 1.0σ level. Additional residues involved in substrate/product recognition are also displayed (for further details see Table 2 ).
A comparison between the glucose-binding sites in the N-and C-terminal domains (of both chains A and B) shows, within the limits of the coordinate experimental error, a striking conservation of structure, residues and enzyme-glucose interactions at the two sites (Table 2) . Similarly, comparison of the G6P-binding sites (N-terminal against C-terminal domain) shows that the two sites differ by the replacement of two residues only. Thr863 substitutes for the N-terminal domain residue Ser415, maintaining, however, two hydrogen bonds to the G6P atom O7* (the asterisk is used to identify oxygen atoms from the 6-phosphate group). On the other hand, residues Ser89 and Asn537, which fall next to the G6P molecule in the N-and C-terminal domains, respectively, do not display direct hydrogen bonding with the ligand. It is therefore difficult to envisage different binding affinities for glucose and for G6P [28] [29] [30] , in the N-and C-terminal domains, respectively, based exclusively on the static structure of the tHK-I bound form reported here.
The non-catalytic ATP-binding site
The crystal structure analysis of rat HK-I has shown that the N-terminal residues (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) , which are mainly responsible for mitochondrial membrane anchoring of the enzyme, adopt a helical structure, proposed to be protruding from the enzyme surface in order to provide efficient interaction with the phospholipid bilayer and porin [4, 5] .
As a result of the symmetric assembly of the A against B subunits, the two N-terminal residues in the dimeric enzyme (residue 12 in tHK-I chain A and residue 16 in chain B) are located approximately 115 Å apart. The protein surface comprised between the two N termini in the assembled dimer shows two distinct, virtually identical zones, which appear as roughly planar and are defined by the 16-34, 365-400, 422-436 helices and by residues 30-31 and 344-347. The two regions, each covering about 650 Å 2 , have an orientation that is approximately perpendicular to the molecular twofold axis (Figures 1,3c,4 ).
Inspection of difference electron-density maps, during the crystallographic refinement of tHK-I has constantly shown strong positive density features at a site located approximately at the centre of each of these two surface regions. The observed electron density, in the N-domains of both A and B subunits, is compatible with a bound AMP-PNP molecule ( Figure 3 ; Table 3 ), which is hosted in a surface cleft defined by helices 16-29, 32-52 (and the connecting 30-31 residues), 335-344, 365-400, 422-436 and by the 344-347 loop. The adenine ring is accommodated at the dead end of the cleft, in stacking interaction with residues Arg30 and Phe380, and in van der Waals contact (<4.0 Å) with residues Thr376 and Ile377. The adenine ring is solvent accessible for 67 Å 2 , its N6 atom being hydrogen bonded to Leu31 O (3.4 Å) and to Asn384 OD1 (3.4 Å) atoms. The AMP-PNP ribose ring is in van der Waals contact with residues Thr376 and Phe380, and is solvent accessible for 80 Å 2 . The ribose O2′ atom is hydrogen bonded to the Arg30 NH2 atom (2.9 Å), and possibly also to the His373 NE2 atom (3.5 Å). The three residues Asp23, Arg30 and His373 form a sort of tight triad, stabilized by mutual hydrogen bonds and electrostatic interactions, which can help in shaping the pocket for productive interaction with the adenosine moiety of the nucleotide. In fact, stacking between the adenine ring and Arg30 guanidino group appears to be instrumental to orientate the arginine sidechain and exploit its hydrogen bonding capability to the ribose O2′ atom [31] . In the absence of the AMP-PNP molecule, in human HK-I [2] , the Arg30 guanidino group is shifted away from the position observed in the presence of the nucleotide. It might also be noted that the ribose O4′ atom is at 3.2 Å from both CD2 and CE2 atoms of Phe380, of which the aromatic ring is seen edge on from the ribose. Such an orientation is strongly suggestive of the presence of a bifurcated hydrogen bond involving the ribose O4′ atom and the two aromatic protons from Phe380 [32] , as an additional contribution to the shaping/stabilization of the adeninebinding pocket.
The phosphate groups of the nucleotide are increasingly exposed to solvent, in the order α → γ, and find electrostatic compensation and hydrogen-bond donors in residues Arg425, Arg426 and Lys429 (Table 3 ; Figure 3 ). The triphosphate tails adopt slightly different conformations in the two tHK-I chains.
The average temperature factors of the bound nucleotides (which were refined with full occupancy) are lower for the adenine rings (48 Å 2 , 40 Å 2 , for subunits A and B, respectively) and for ribose (49 Å 2 and 46 Å 2 , respectively), reflecting the temperature factors of the neighbouring protein residues, whereas they are higher for the phosphate groups (averages for the triphosphate tails are 82 Å 2 and 77 Å 2 ). Such an atomic B factor increase along the nucleotide molecule can be interpreted as the result of increased flexibility, being in fact related to the varying levels of solvent exposure and protein-AMP-PNP interactions observed. 
(c)
Structure
In both tHK-I chains a strong electron density feature is observed next to the nucleotide βand γ-phosphate groups, at distances of 2.5-3.2 Å from the phosphate oxygen atoms, although with slightly different interactions in the two chains. In consideration of the crystallization buffer composition, these electron-density peaks could be interpreted as Mg 2+ ions (the crystallographic refinement of which, at full occupancy, yields B factors of approximately 70 Å 2 ). Alternatively, in view of their solvent exposed location, such electron density features might represent alternative conformations for the nucleotide triphosphate tail, or a different tightly bound solvent species.
A structural overlay of the tHK-I structure, in the presence of the nucleotide, with that of nucleotide-free human HK-I, focussed on the region of AMP-PNP binding, shows a substantial conservation of the protein structure (rmsd over 88 Cα is 0.4 Å), a conservation that essentially extends to the sidechain conformations of residues building up the adenine-ribose pocket, with the exception of Arg30. Thus, AMP-PNP binding does not appear to require significant structural adaptation on the enzyme side, nor do structural rearrangements seem to be transmitted from the AMP-PNP-binding site (in the N-terminal domain) to the enzyme active site, which is 82 Å away (in the C-terminal domain).
Inspection of the tHK-I refined structure in the surface region surrounding the AMP-PNP-binding site shows a notable distribution of 17 positively charged residues, five of which are involved in direct protein-AMP-PNP interaction ( Table 3 ; Figure 4 ). Such a structural localization of positively charged residues surrounding the nucleotide binding site, all belonging to the N-terminal domain, supports the hypothesis of a membrane interface location for this molecular region, which would stabilize the interaction between HK-I and the mitochondrion through the establishment of ionic interactions with the membrane phospholipid phosphate heads. Indeed, binding of the enzyme is influenced by the phospholipidic composition of the membrane [33] .
It has been shown previously that triphosphate nucleotides favour HK-I dissociation from the membrane, an effect that can be partly reversed by the addition of Mg 2+ [19, [34] [35] [36] .
The model presented here shows that AMP-PNP binding to tHK-I occurs at an N-terminal domain site, the structural features of which are those of a nucleotide-recognition pocket endowed with broad specificity. Indeed, a very simple modelling approach shows that such a site can easily accommodate di-or tri-phosphate nucleotides other than ATP. The simultaneous exposure of their negatively charged tri-or di-phosphate tails to the mitochondrial membrane interface would decrease the amount of protein-membrane electrostatic attraction, promoting enzyme solubilization. A similar HK-I membrane dissociation effect can also be induced by the addition of pyrophosphate, but not of phosphate, which might be too small to bind effectively at the proposed non-catalytic nucleotide site. On the contrary, the addition of Mg 2+ would partly
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Figure 4
Electrostatic residues around the non-catalytic nucleotide binding site. A stereoview of the tHK-I surface that hosts the AMP-PNPbinding site in chain B, drawn approximately edge on (rotated about 90° with respect to Figure 3c ). The AMP-PNP molecule (green) is displayed together with the positively charged residues (blue) which are proposed to favour outer mitochondrial membrane association (also see Figure 5 ).
N terminus N terminus
Structure Table 3 Hydrogen-bond interactions observed at AMP-PNP-binding sites in A and B chains of tHK-I. compensate for the electrostatic repulsion resulting from nucleotide binding to the enzyme, antagonizing, as previously observed [34] , the nucleotide tri-phosphate solubilization effects. It should be noticed, in this respect, that potential Mg 2+ -binding sites have been located on the phosphate tails of both AMP-PNP molecules in the tHK-I structure reported here.
AMP-PNP A chain
In agreement with the above mechanistic hypotheses, the recombinant N-terminal tHK-I domain (residues 12-454) was found to be able to bind to RED A columns (Amicon Corp, Lexington). This affinity column support displays negative groups and is used commonly for the purification of nucleotide binding enzymes [37] . Remarkably, the N-terminal tHK-I domain was selectively eluted by 2 mM ATP, but not by 2 mM Mg-ATP nor by 1.5 mM G6P (M Magnani and G Serafini, unpublished observations).
The above structural results and model for HK-I-membrane interaction is furthermore consistent with monoclonal antibody mapping experiments, conducted on the intact rat HK-I molecule, which have shown that: firstly, outer mitochondrial membrane binding can be fully ascribed to the N-terminal half of the enzyme; and secondly, additional interactions, besides those related to the N-terminal anchoring helix, promote the HK-I (or HK-II) membrane association. Particularly, in a combination of monoclonal antibody protection experiments, sequence analysis and antibody recognition of the mitochondrially bound enzyme, it was shown that HK-I segments 1-9, 36-60, and 365-385, all physically located in the N-terminal 'large subdomain', are primarily involved in enzyme-outer mitochondrial membrane contacts [18, 21] . Remarkably, these protein segments match, within the spatial resolution allowed by antibody mapping, the region observed around the non-catalytic ATP-binding site in the crystal structure of the tHK-I-AMP-PNP complex (Figures 3,4) . Incidentally, we note that specific localization of HK-I at the mitochondrial membrane contact sites might be driven by association of a yet unidentified membrane (or porin) bound species to the N-terminal domain non-catalytic nucleotide-binding cleft, a locating process which is exploited by different membrane associated protein systems [38] .
As discussed above, the AMP-PNP molecule makes extensive interactions with the tHK-I protein matrix, a feature observed in several unrelated ATP-dependent proteins and recognized as an essential requirement for productive ATP recognition [39, 40] . Remarkably, despite the absence of secondary structure homologies, the non-catalytic ATPbinding site in tHK-I provides cofactor recognition through a network of interactions that are topologically and chemically reminiscent of those observed in cAMP-dependent protein kinase and in D-Ala-D-Ala ligase, in which ATP plays a catalytic role [39] . Such an observation is in keeping with the view that proteins with unrelated folds can host similar localized structural features in order to satisfy ATP recognition. In this context, however, tHK-I represents a unique case, in that it displays two different ATP-binding sites (in two separate domains) meeting the requirements of catalysis and of regulation of mitochondrial membrane association, respectively.
An additional argument for discussion, in this context, concerns the structural/evolutionary divergence of the proposed non-catalytic ATP-binding site, observed in the tHK-I N-terminal domain, as compared with the homologous region in the C-terminal domain, which does not bind to mitochondria as an isolated domain. A superposition of the non-catalytic ATP-binding site, observed in the tHK-I N-terminal domain, with the structurally homologous region from the C-terminal domain shows the substitution of three charged residues (Arg426, Lys429 and Arg433) with neutral or negatively charged residues (Ile874, Gln877 and Glu881, respectively; see Figure 5 ). Moreover, the Phe380→Arg828 substitution might affect the polarity of the adenine-binding cleft and the location of Arg30, whereas the presence of Gly824 (substituting for Thr376) might influence the binding mode of the incoming nucleotide ribose ring.
From a more general viewpoint, Figure 5 shows a structure-based comparison of amino acid residues from the tHK-I non-catalytic ATP-binding region versus structurally equivalent residues from the N-and C-terminal domains of other hexokinase enzymes, of which the mitochondrial membrane binding behaviours are known. Such a comparison allows one to recognize the following general properties. HK-I N-terminal domains display full conservation of the residues involved in recognition of the nucleotide analogue, including Arg30 and Phe380, which provide stacking interaction with the adenine ring. Moreover, the charged surface residues that are expected to provide electrostatic interaction with the mitochondrial membrane, on the basis of the present crystallographic model, are fully conserved in human and rat HK-I enzymes. HK-II enzymes, which are also known to bind at the mitochondrial membrane, show the least amino acid variation from this trend in their N-terminal domains. On the other hand, such a pattern is definitely altered (with loss or inversion of electrostatic charges) in the C-terminal domains of HK-I and HK-II, in both domains of HK-III, in glucokinase and in the enzymes from S. mansoni and yeast ( Figure 5 ). Remarkably, non-conservative substitution of the non-catalytic ATP-binding site residues and perturbation of the electrostatics-linked residues is constantly observed in the hexokinase domains that are not capable of outer mitochondrial membrane binding.
A final issue concerns the solubilization effects that are induced on the mitochondrially bound HK-I by the action of G6P. In this respect it should be considered that the rat and human HK-I have been crystallized under different growth conditions, in the presence of at least 1 mM G6P, in the presence/absence of AMP-PNP (this work and [2, 5] ).
As discussed above, all these crystal structures show that the product is bound to both N-and C-terminal domains, at a protein internal location, next to the glucose-binding site. Moreover, even at 10 mM G6P levels, a concentration 50fold higher than that required for HK-I solubilization from the mitochondrial membrane [19] , no enzyme surface location, including the AMP-PNP site identified here, displays electron density compatible with a bound G6P molecule.
Although it cannot be excluded that the closed-dimeric form of HK-I reported in the crystalline state reflects only an inhibited-latent enzyme structure, the above observations might indicate that the G6P effects on HK-I solubilization are indirect, as compared with those proposed here for tri-and di-nucleotide action. In particular, G6P-induced solubilization might occur as a result of a perturbation of the HK-I tetramer formation process at the mitochondrial membrane [16] . Indeed, dissociation of tetrameric HK-I might be promoted by a G6P-induced conformational shift towards the closed form. Alternatively, G6P might promote HK-I solubilization by binding to a mitochondrial membrane component, tightly associated with HK-I at the membrane contact sites. Such an hypothesis is consistent with the above reported observation that tHK-I is not eluted from RED A columns by 1.5 mM G6P (M Magnani and G Serafini, unpublished observations), and with the known species dependence of the G6P-induced HK-I solubilization. Indeed, it is known that although rat HK-I can be almost completely released from mitochondria by the action of G6P, only 20% of the human brain enzyme can be solubilized under similar conditions [20] .
Biological implications
Hexokinase catalyzes the ATP-dependent phosphorylation of glucose to glucose-6-phosphate (G6P), the entry point of glucose into glycolysis. Sequence and functional data indicate that for two mammalian hexokinase isozymes (HK-I and HK-III, both approximately 100 kDa) the catalytic activity is associated with the C-terminal half of the molecule, whereas the N-terminal domain has regulatory properties. HK-I activity is inhibited by the enzymatic reaction product, G6P; binding of P i to the enzyme N-terminal domain relieves G6P inhibition. The details and structural bases of both processes, which include transmission of allosteric signals between the two domains, at least in the case of P i activation, and competition with catalytic ATP binding to the active site, are still widely debated.
At least for HK-I and HK-II, the N-terminal domain promotes association to the outer mitochondrial membrane contact sites. In fact, approximately 70% of human brain HK-I is bound to mitochondria, presumably in a tetrameric form, in association with mitochondrial porin (a voltage-dependent anion channel). Such structural organization has been proposed to allow preferential diffusion of ATP (produced by mitochondrial oxidative phosphorylation) to the HK-I catalytic centre, providing at the same time the mitochondrial space with a constant flux of ADP, as a result of HK-I catalyzed glucose phosphorylation. Given that the rate of the two processes (glucose phosphorylation by HK-I and intramitochondrial oxidative phosphorylation) correlate, HK-I might act as a coordinator enzyme, preventing an imbalance of glycolytic reactions over mitochondrial oxidative reactions, which could lead to the accumulation of (neurotoxic) lactate. In an excess of ATP, HK-I Research Article Hexokinase-I-AMP-PNP complex Rosano et al. 1435
Figure 5
Evolutionary conservation of residues around the non-catalytic ATP binding site. The tHK-I amino acid residues that are proposed to be involved in tHK-I membrane binding (on the basis of the present crystallographic investigation) are compared with structurally equivalent residues from the N-terminal domains of different hexokinase molecules that are known to bind to the mitochondrial membrane (N-terminal domains of rat HK-I, and human and rat HK-II), with the domains of hexokinase molecules that do not bind to the mitochondrial membrane (N-terminal domains of human and rat HK-III, glucokinase; all C-terminal domains) and with the hexokinase molecules from S. mansoni and from yeast. Residue sites that are directly involved in AMP-PNP binding are indicated by bold numbers (see also Figure 4 ; amino acid numbering refers to tHK-I sequence). dissociates from the mitochondria with a reported reduction of its catalytic efficiency. Regulation of the cytoplasmic glycolytic flux would then be achieved only through the G6P (product) inhibition mechanisms.
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Binding of HK-I to mitochondria is dependent on the insertion of an 11-residue N-terminal helical segment into the phospholipid bilayer. This property has been elegantly transferred to unrelated proteins by grafting this segment to their N termini. Antibody protection experiments and construction of hybrid molecules incorporating different hexokinase domains, however, show that other HK-I regions, located in the N-terminal 'large subdomain', participate in the process of membrane association. Binding of hexokinase to the outer mitochondrial membrane is tissue specific and developmentally regulated, the enzyme activity being markedly elevated in several cancer cells.
The crystal structure of recombinant human HK-I, in complex with glucose, G6P and with the nonhydrolyzable ATP analogue 5′-adenylylimido diphosphate, allows us to locate a protein surface cleft that displays the characteristics of a broad specificity nucleotide-binding site. In the dimeric HK-I, the two nucleotide-binding sites are related by a molecular twofold axis and fall at the centre of two wide molecular regions, rich in positively charged residues, which can face simultaneously an approaching mitochondrial membrane. Thus, in the absence of bound ATP and in addition to the known insertion of the N-terminal helix in the phospholipid bilayer, electrostatic interactions can help secure the enzyme to the membrane phospholipidic heads. On the basis of the threedimensional structure reported in this paper, the tHK-I solubilization effects (with respect to mitochondria) related to the addition of ATP, nucleotides and pyrophosphate, as well as the contrasting role played by Mg 2+ ions, might be explained by the perturbation of such enzyme-membrane electrostatic interactions.
Materials and methods
Expression and purification
The tHK-I gene was expressed as recombinant enzyme in BL21(DE3) Escherichia coli cells, using the pET system, inducible with IPTG. Details about optimization of human recombinant HK-I expression in bacteria are reported by Bianchi et al. [41] . Next, tHK-I was purified to homogeneity following the purification procedure used for the full-length recombinant enzyme [42] , with the only exception that the elution buffer for the Blue A column contained 40 mM potassium chloride (KCl) instead of 90 mM KCl.
Crystallization
An extensive search for suitable crystal growth conditions was carried over using sparse matrix crystallization kits (Hampton Research, Laguna Hills, CA). After refinement of the physico-chemical parameters, crystals with dimensions often exceeding 0.3 × 0.2 × 0.1 mm 3 were obtained, in the hanging-drop geometry at 4°C using a 700 µl reservoir solution containing 15% (w/v) PEG 8K, 200 mM magnesium acetate, 100 mM sodium acetate, 10% (v/v) glycerol, 3 mM β-mercaptoethanol, pH 5.5. The 6 µl droplet used contained 4 µl of protein solution (15 mg/ml in diluted buffer, 10 mM glucose, 3 mM β-mercaptoethanol, 9% (v/v) glycerol, 40 mM KCl, 1.5 mM G6P), 1 µl of reservoir medium and 1 µl of 60 mM AMP-PNP in water [43] .
Data collection and reduction
Diffraction data were firstly collected in-house and subsequently using synchrotron radiation at the ID14 beamline, European Synchrotron Radiation Facility (λ = 0.936 Å). Crystal were cryo-frozen at 100K using a modified mother liquor solution that contained all the protein droplet components and 15% (v/v) glycerol, as cryoprotectant. A single crystal was used to collect the 2.25 Å resolution diffracted intensities, which were processed and reduced using the programs XDISP, DENZO and SCALEPACK of the HKL package [44] . The tHK-I crystals belong to the monoclinic P2 1 space group with unit cell constants a = 82.4 Å, b = 174.3 Å, c = 86.3 Å, β = 90.5° and contain one dimer per asymmetric unit. A summary of the data collection and reduction statistics is given in Table 1 .
Structure determination and refinement
The structure of tHK-I was determined by molecular replacement methods using the program AMoRe [22] of the CCP4 suite. Rotational searches in the 12.0-5.0 Å resolution range were carried over using the atomic coordinates of a previously determined human hexokinase (PDB code 1hkb) as the search model. Two peaks with correlation values of 14.9 (11σ) and 13.5 (10σ), respectively, were promptly found. The third rotation function peak had a correlation coefficient of 9.5. Translational searches were carried out in an iterative manner in the 12.0-5.5 Å resolution range, yielding two solutions with correlation coefficients of 34.0 and 33.7 respectively; the corresponding R factor was 47.1% (12.0-5.5 Å resolution range). Subsequently, rigid-body refinement of the two solutions at 4.5 Å resolution yielded a R factor value of 37.7% (correlation coefficient of 65.5). Further rigid-body refinement of the two tHK-I chains, each divided into two independent domains (N-and C-terminal), did not provide any significant protein readjustment. A random set of reflections (5%) was flagged for R free calculation and several cycles of simulated annealing/slow cooling were performed using the X-PLOR package [45] , with R factor drop to 29.9% (R free = 35.2%) in the 8.0-3.5 Å resolution range. The model obtained was then subjected to 237 cycles of maximum likelihood refinement using REFMAC [46] and including bulk solvent correction. The macromolecular model was continuously inspected against difference Fourier maps and corrections made accordingly [47] . Solvent molecules were located at stereochemically acceptable sites. The final model (R factor 20.8%, R free 27.9%, for all reflections observed in the 10.0-2.25 Å resolution range) conforms quite satisfactorily to the accepted statistics for protein stereochemical parameters [23, 48] (Table 1) .
Accession numbers
Atomic coordinates for tHK-I and structure factors have been deposited with the Protein Data Bank [49] as dataset 1qha.
